US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
Das könnte Ihnen auch gefallen
Gewinner
Neueste Krypto-Nachrichten
Trump: Fed Chair Nominee bestätigt
Jahr der Finanzierung des Angriffs verdächtigt, Hacker schickt 1.000 ETH gestohlener Gelder an Tornado Cash
Ethereum fällt unter $3.000, 24-Stunden-Verlust von 0,25%
Die wichtigsten Ereignisse und Datenvorschau dieser Woche: Powell Speech, US PCE und ADP Nonfarm Payrolls
Entität: Der KI-Sektor ist derzeit einem relativ geringen Überbelegungsrisiko ausgesetzt, und langfristige Chancen bestehen noch
Kundenservice:@weikecs
Geschäftliche Zusammenarbeit:@weikecs
Quant-Trading & MM:[email protected]
VIP-Services:[email protected]